Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vitiligo Registry for Adults and Children in the UK
Sponsor: The Royal Wolverhampton Hospitals NHS Trust
Summary
Vitiligo is the most common depigmentation disorder affecting around 1% of the population worldwide. Fifty two percent of patients develop vitiligo before the age of 20 and around 80% develop vitiligo before the age of 30 years old.1 Vitiligo often presents in childhood and tends to be a lifelong disease, requiring prolonged courses of phototherapy. Currently no national or international registry for patients with vitiligo exists. Individual dermatologists maintain a database of such patients, however no coordinated efforts have been made to combine these individual registries into a broader national registry. Finally, recently published British Association of Dermatologists (BAD) guideline for the management of vitiligo, recommended the development of a national registry for people with vitiligo undergoing systemic or light therapy to identify outcomes and safety.
Official title: Vitiligo Registry for Adults and Children in the UK (VIRTUAL-UK)
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-05-15
Completion Date
2030-02
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Locations (1)
The Royal Wolverhampton NHS Trust
Wolverhampton, United Kingdom